Dysregulation of endothelial mitochondrial dynamics is hypothesized to play a crucial role in endothelial microvascular dysfunction in individuals with coronary artery disease.
Does regulation of endothelial mitochondrial dynamics improve outcomes in individuals with coronary artery disease?
This hypothesis paper suggests that targeting mitochondrial dynamics to restore endothelial function could be a novel therapeutic approach for patients with coronary artery disease.
The endothelial microvasculature is essential for the regulation of vasodilation and vasoconstriction, and improved functioning of the endothelium is linked to improved outcomes for individuals with coronary artery disease (CAD). People with endothelial dysfunction exhibit a loss of nitric oxide (NO)-mediated vasodilation, achieving vasodilation instead through mitochondria-derived H 2 O 2 . Mitochondrial dynamics is an important autoregulatory mechanism that contributes to mitochondrial and endothelial homeostasis and plays a role in the formation of reactive oxygen species (ROS), including H 2 O 2 . Dysregulation of mitochondrial dynamics leads to increased ROS production, decreased ATP production, impaired metabolism, activation of pathological signal transduction, impaired calcium sensing, and inflammation. We hypothesize that dysregulation of endothelial mitochondrial dynamics plays a crucial role in the endothelial microvascular dysfunction seen in individuals with CAD. Therefore, proper regulation of endothelial mitochondrial dynamics may be a suitable treatment for individuals with endothelial microvascular dysfunction, and we furthermore postulate that improving this microvascular dysfunction will directly improve outcomes for those with CAD.
Gutierrez‐Huerta et al. (Tue,) conducted a review in Coronary artery disease. Regulation of endothelial mitochondrial dynamics was evaluated. Dysregulation of endothelial mitochondrial dynamics is hypothesized to play a crucial role in endothelial microvascular dysfunction in individuals with coronary artery disease.